ATLASOrchestra BioMed (OBIO) earnings date: Nov 9, 2026
Orchestra BioMed (OBIO) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$0.40.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on OBIO
| Last price | $5.69 (-3.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Orchestra BioMed stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Orchestra BioMed reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Orchestra BioMed. You can switch it off at any time.
Alert me before OBIO reportsFree to start. Creating an account takes under a minute.
Notify me when Orchestra BioMed reports
Track OBIO free Add Orchestra BioMed to a free ATLAS watchlist and see its next report date in one place.
OBIO earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.40 |
| Last report | Aug 10, 2026 · In line |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +59.2% |
| Average move around a report | ±5.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Orchestra BioMed earnings history: last 4 reports
Orchestra BioMed last reported on Aug 10, 2026: EPS of -$0.37 against an estimate of -$0.37 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.37 | -$0.37 | 0.0% | In line | +3.8% |
| Jul 24, 2026 | $1.55 | $1.68 | +8.4% | Beat | +5.0% |
| Jun 18, 2026 | -$0.20 | -$0.08 | +60.0% | Beat | +5.4% |
| Mar 12, 2026 | -$0.38 | $0.26 | +168.4% | Beat | -8.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for OBIO
See the fair value, the probability range and the earnings history of Orchestra BioMed on its ATLAS page.
Orchestra BioMed (OBIO) stock analysisPlans from €3.99 a month.
Orchestra BioMed earnings: frequently asked questions
When does Orchestra BioMed (OBIO) report earnings?
Orchestra BioMed is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for OBIO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.40 per share (USD). Estimates can change before the report.
How often does OBIO beat earnings estimates?
Of its last 4 reports with a recorded result, Orchestra BioMed beat the EPS estimate 3 times; the average surprise was +59.2%. Past results do not predict the next one.
How much does OBIO move around earnings?
Over its last 4 reports the stock moved an average of 5.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Orchestra BioMed beat earnings estimates last quarter?
Orchestra BioMed last reported on Aug 10, 2026: EPS of -$0.37 against an estimate of -$0.37 (0.0% surprise), in line with the estimate.
How much does OBIO usually move in a day?
On a normal trading day the ATLAS model puts OBIO’s one-day range at about ±3.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer